IP Library › Granted Patent US 12,569,371
Granted Patent B2
US 12,569,371 · App. 18/198,469 · Granted Mar 10, 2026

Sterilization of medical dressings with enhanced antimicrobial properties

Inventors: Thomas J. Drury (Narragansett, RI); John E. O'Gara (Ashland, MA); Christopher Hanson (East Hampton, CT); John Mantese (Ellington, CT)
Assignee: HYDROFERA, LLC
A61F13/00063A61F13/00059A61F13/01017A61F13/01021A61F13/05A61L2/081A61L2/20A61L2/206A61L15/225A61L15/24A61L15/26A61L15/425A61L15/44A61L15/58A61F2013/00336A61F2013/429A61F2013/530649A61L2103/05A61L2103/15A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,569,371
App. No.
18/198,469
Granted
Mar 10, 2026
Kind
B2
Abstract

The present invention relates to a sponge dressing for treating wounds comprised of a polymer sponge containing a plurality of antimicrobial dyes with at least one dye being gram positive and at least one other dye being gram negative and a silicon adhesive secured to a sponge surface. The sponge dressing can be exposed initially to gamma radiation and later sterilized by ethylene oxide or alternatively it can be sterilized by ethylene oxide and later irradiated by gamma radiation. The sponge dressing has a morphology characterized by an average pore throat diameter of 0.5-500 μm and a porosity ranging from about 60% to about 99.5%. The sponge dressing can also contain at least one biofilm reducing agent, at least one chelating agent and an ionic and non-ionic surfactant.

Claims (23)

1 . A process of sterilizing a dressing, the process comprising:

exposing the dressing to gamma radiation; and

sterilizing the dressing with ethylene oxide,

wherein:

the process comprises exposing the dressing to gamma radiation prior to sterilizing the dressing with ethylene oxide,

the dressing comprises a polymer sponge comprising polyvinyl formal polyvinyl acetal, polyurethane, or a mixture of said polymers and containing a gram negative dye and a gram positive dye, and

the gamma irradiation increases antibacterial dye effectiveness of the polymer sponge treated with ethylene oxide sterilization.

2 . The process of claim 1 , wherein exposing the dressing to gamma radiation comprises exposing the dressing to gamma radiation for a period suitable to apply gamma radiation ranging from about 5 to about 36 kilogray to the dressing.

3 . The process of claim 1 ,

wherein the gram positive dye and the gram negative dye comprise a triaryl or diarylmethane, methylene blue, toluidine blue, methylene violet, azure A, azure B, azure C, brilliant cresol blue, thionin, methylene green, bromcresol green, crystal violet, acridine orange, brilliant green, acridine yellow, quinacrine, trypan blue, trypan red, or a combination thereof.

4 . The process of claim 3 , wherein:

the gram negative dye comprises methylene blue; and

the gram positive dye comprises crystal violet.

5 . The process of claim 1 , wherein the dressing further comprises a silicon adhesive.

6 . The process of claim 1 , wherein the polymer sponge comprises polyvinyl formal.

7 . The process of claim 1 , wherein the polymer sponge comprises polyvinyl acetal.

8 . The process of claim 1 , wherein the polymer sponge comprises polyurethane.

9 . The process of claim 1 , wherein the polymer sponge has an average pore throat diameter of 0.5-500 μm.

10 . The process of claim 1 , wherein the polymer sponge has a fluid retention of 5.5-25.0 mL fluids/g porous material.

11 . The process of claim 1 , wherein the polymer sponge has a density of 0.05-0.15 g polymer/cm 3 porous material.

12 . The process of claim 3 , wherein exposing the dressing to gamma radiation improves antimicrobial effectiveness of the gram positive dye and the gram negative dye in the dressing against Staphylococcus aureus above antimicrobial effectiveness of the gram positive dye and the gram negative dye in the dressing against Staphylococcus aureus treated with only ethylene oxide.

13 . The process of claim 3 , wherein exposing the dressing to gamma radiation improves antimicrobial effectiveness of the gram positive dye and the gram negative dye in the dressing against Escherichia coli above antimicrobial effectiveness of the gram positive dye and the gram negative dye in the dressing against Escherichia coli treated with only ethylene oxide.

14 . The process of claim 3 , wherein exposing the dressing to gamma radiation improves antimicrobial effectiveness of the gram positive dye and the gram negative dye in the dressing against Pseudomonas aeruginosa above antimicrobial effectiveness of the gram positive dye and the gram negative dye in the dressing against Pseudomonas aeruginosa treated with only ethylene oxide.

Continuity (3)
Division 16602440 · Oct 7, 2019
Provisional Application 62749902 · Oct 24, 2018
Related Publication 20230285197A1 · Sep 14, 2023
References Cited (56)
US 3572340A · Lloyd et al. · 1971 [cited by applicant]
US 4525166A · Leclerc · 1985 [cited by applicant]
US 5811471A · Shanbrom · 1998 [cited by applicant]
US 5908693A · Delgado et al. · 1999 [cited by applicant]
US 6207875B1 · Lindqvist et al. · 2001 [cited by applicant]
US 7569742B2 · Haggstrom et al. · 2009 [cited by applicant]
US 9084845B2 · Adie et al. · 2015 [cited by applicant]
US 9480830B1 · Azocar · 2016 [cited by applicant]
US 9974890B2 · Hudspeth et al. · 2018 [cited by applicant]
US 10046096B2 · Askem et al. · 2018 [cited by applicant]
US 11147696B2 · Scanlon et al. · 2021 [cited by applicant]
US 11273077B2 · Kubek · 2022 [cited by applicant]
US 20060030632A1 · Krueger · 2006 [cited by examiner]
US 20100160881A1 · Lin et al. · 2010 [cited by applicant]
US 20100324510A1 · Andresen et al. · 2010 [cited by applicant]
US 20110045072A1 · da Cruz · 2011 [cited by examiner]
US 20110060204A1 · Weston · 2011 [cited by applicant]
US 20110091353A1 · Burgess et al. · 2011 [cited by applicant]
US 20110092958A1 · Jacobs · 2011 [cited by applicant]
US 20110178451A1 · Robinson et al. · 2011 [cited by applicant]
US 20110230849A1 · Coulthard et al. · 2011 [cited by applicant]
US 20120078155A1 · Bowman et al. · 2012 [cited by applicant]
US 20120157750A1 · Robinson et al. · 2012 [cited by applicant]
US 20130032967A1 · Wang et al. · 2013 [cited by applicant]
US 20140018654A1 · Drury · 2014 [cited by applicant]
US 20140163490A1 · Locke et al. · 2014 [cited by applicant]
US 20140275864A1 · Drury · 2014 [cited by examiner]
US 20150351970A1 · Dagger et al. · 2015 [cited by applicant]
US 20160361478A1 · Eddy · 2016 [cited by applicant]
US 20170296383A1 · Friedman et al. · 2017 [cited by applicant]
US 20180093013A1 · Dehnad et al. · 2018 [cited by applicant]
US 20180257059A1 · Heo et al. · 2018 [cited by applicant]
US 20180263823A1 · Chatterjee · 2018 [cited by applicant]
US 20180264181A1 · Gregory et al. · 2018 [cited by applicant]
US 20180289872A1 · Coulthard et al. · 2018 [cited by applicant]
US 20180296395A1 · Kubek · 2018 [cited by applicant]
US 20180296397A1 · Askem et al. · 2018 [cited by applicant]
US 20180296712A1 · Dobrinsky et al. · 2018 [cited by applicant]
US 20180338945A1 · Sambasivam · 2018 [cited by applicant]
US 20180344533A1 · Rovaniemi · 2018 [cited by applicant]
US 20180369462A1 · Anderson et al. · 2018 [cited by applicant]
US 20200078499A1 · Gadde et al. · 2020 [cited by applicant]
US 20200129339A1 · Drury et al. · 2020 [cited by applicant]
US 20200129340A1 · Drury et al. · 2020 [cited by applicant]
US 20200129648A1 · Drury · 2020 [cited by examiner]
US 20200345888A1 · O'Gara et al. · 2020 [cited by applicant]
US 20210100929A1 · Dizio et al. · 2021 [cited by applicant]
US 20230310219A1 · Drury et al. · 2023 [cited by applicant]
WO 2010056544A1 · 2010 [cited by applicant]
WO 2017075320A1 · 2017 [cited by applicant]
U.S. Appl. No. 16/602,439; Final Office Action dated Sep. 21, 2023; 30 pages. [cited by applicant]
U.S. Appl. No. 16/602,519; Final Office Action dated Jun. 29, 2023; 21 pages. [cited by applicant]
U.S. Appl. No. 18/196,079; Final Office Action dated Sep. 12, 2024; 15 pages. [cited by applicant]
U.S. Appl. No. 18/196,079; Non-Final Office Action dated May 8, 2024; 21 pages. [cited by applicant]
Chrzanowska et al. “Elaboration of small-diameter vascular prostheses-Selection of appropriate sterilisation method.” Journal of Applied Polymer Science 131.18 (2014). 10 pages. [cited by applicant]
Hsiao et al. “The influence of γ irradiation and ethylene oxide treatment on the release characteristics of biodegradable poly(lactide-co-glycolide) composites.” Polymer degradation and stability 97.5 (2012): 715-720. [cited by applicant]